Advertisement
Advertisement

HBIO

HBIO logo

Harvard Bioscience Inc

6.08
USD
Sponsored
+0.07
+1.16%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

6.11

+0.03
+0.49%

HBIO Earnings Reports

Positive Surprise Ratio

HBIO beat 16 of 42 last estimates.

38%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$21.88M
/
-$0.43
Implied change from Q1 26 (Revenue/ EPS)
+5.42%
/
+30.30%
Implied change from Q2 25 (Revenue/ EPS)
+6.99%
/
+330.00%

Harvard Bioscience Inc earnings per share and revenue

On May 12, 2026, HBIO reported earnings of -0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.63 USD, resulting in a 47.82% surprise. Revenue reached 20.75 million, compared to an expected 21.62 million, with a -4.02% difference. The market reacted with a -20.91% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 21.88 million USD, implying an increase of 30.30% EPS, and increase of 5.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kewaunee Scientific Corp
Report Date
Jun 23, 2026 For Q4 26
Estimate
-
Actual
$1.13
Surprise
-
FAQ
For Q1 2026, Harvard Bioscience Inc reported EPS of -$0.33, beating estimates by 47.82%, and revenue of $20.75M, -4.02% below expectations.
The stock price moved down -20.91%, changed from $6.84 before the earnings release to $5.41 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 4 analysts, Harvard Bioscience Inc is expected to report EPS of -$0.43 and revenue of $21.88M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement